Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 326 of 1,261
  1. US 11071728

    Treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  2. US 11072618

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  3. US 11071784

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  4. US 11071749

    Oligonucleotide analogues targeting human LMNA

    Sarepta Therapeutics, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  5. US 11072781

    Genomic engineering of pluripotent cells

    Fate Therapeutics, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  6. US 11072644

    Inhibitory chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  7. US 11072639

    Bi-functional anti-tau polypeptides and use thereof

    REGENERATIVE RESEARCH FOUNDATION · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  8. US 11072579

    Treatment of cataplexy

    Jazz Pharmaceuticals Ireland Limited · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  9. US 11071778

    Combination product for use in tumor vaccination

    DCPRIME B.V. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  10. US 11071727

    Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors

    Northwestern University · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  11. US 11072629

    Reprogramming of cellular adhesion

    The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  12. US 11072606

    Compositions and methods for treating diseases and conditions

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  13. US 11072636

    Peptide for inhibiting angiogenesis and use thereof

    CAREGEN CO., LTD. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  14. US 11072600

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  15. US 11072592

    Small molecules that enable cartilage rejuvenation

    The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  16. US 11072581

    N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

    Oxford Drug Design Limited · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  17. US 11072598

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  18. US 11072594

    Trioxolane agents

    The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  19. US 11071787

    Topiramate compositions and methods of making and using the same

    Regents of the University of Minnesota · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  20. US 11071781

    Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

    Provectus Pharmatech, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  21. US 11071759

    Methods for treating ulcerative colitis

    Finch Therapeutics Holdings LLC · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  22. US 11071780

    Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  23. US 11071742

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  24. US 11071782

    Method of filling a container with no headspace

    Coherus BioSciences, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.